UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pin1 Exacerbates Non-Alcoholic Fatty Liver Disease by Enhancing Its Activity through Binding to ACC1

International journal of molecular sciences, 2024-06, Vol.25 (11), p.5822

2024

Volltextzugriff (PDF)

Potential of the Antibody Against cis-Phosphorylated Tau in the Early Diagnosis, Treatment, and Prevention of Alzheimer Disease and Brain Injury

JAMA neurology, 2016-11, Vol.73 (11), p.1356

2016

Volltextzugriff (PDF)

Pin1 inhibition reverses the acquired resistance of human hepatocellular carcinoma cells to Regorafenib via the Gli1/Snail/E-cadherin pathway

Cancer letters, 2019-03, Vol.444, p.82-93

2019

Volltextzugriff (PDF)

Pin1 Downregulation Is Involved in Excess Retinoic Acid-Induced Failure of Neural Tube Closure

International journal of molecular sciences, 2024-06, Vol.25 (11), p.5588

2024

Volltextzugriff (PDF)

Disorders of the central nervous system: Insights from Notch and Nrf2 signaling

Biomedicine & pharmacotherapy, 2023-10, Vol.166, p.115383-115383, Article 115383

2023

Volltextzugriff (PDF)

Lead Induces Genotoxicity via Oxidative Stress and Promoter Methylation of DNA Repair Genes in Human Lymphoblastoid TK6 Cells

Medical science monitor, 2018-06, Vol.24, p.4295-4304

2018

Volltextzugriff (PDF)

A novel controlled release formulation of the Pin1 inhibitor ATRA to improve liver cancer therapy by simultaneously blocking multiple cancer pathways

Journal of controlled release, 2018-01, Vol.269, p.405-422

2018

Volltextzugriff (PDF)

Targeting PIN1 exerts potent antitumor activity in pancreatic ductal carcinoma via inhibiting tumor metastasis

Cancer science, 2019-08, Vol.110 (8), p.2442-2455

2019

Volltextzugriff (PDF)

TCP1 regulates Wnt7b/β-catenin pathway through P53 to influence the proliferation and migration of hepatocellular carcinoma cells

Signal transduction and targeted therapy, 2020-08, Vol.5 (1), p.169-169, Article 169

2020

Volltextzugriff (PDF)

MicroRNA-140-5p inhibits hepatocellular carcinoma by directly targeting the unique isomerase Pin1 to block multiple cancer-driving pathways

Scientific reports, 2017-04, Vol.7 (1), p.45915-45915, Article 45915

2017

Volltextzugriff (PDF)

Regorafenib inhibits migration, invasion, and vasculogenic mimicry of hepatocellular carcinoma via targeting ID1‐mediated EMT

Molecular carcinogenesis, 2021-02, Vol.60 (2), p.151-163

2021

Volltextzugriff (PDF)

The role of peptidyl-prolyl isomerase Pin1 in neuronal signaling in epilepsy

Frontiers in molecular neuroscience, 2022-10, Vol.15, p.1006419-1006419

2022

Volltextzugriff (PDF)

Chemical or genetic Pin1 inhibition exerts potent anticancer activity against hepatocellular carcinoma by blocking multiple cancer-driving pathways

Scientific reports, 2017-03, Vol.7 (1), p.43639-43639, Article 43639

2017

Volltextzugriff (PDF)

Inhibition of the prolyl isomerase Pin1 enhances the ability of sorafenib to induce cell death and inhibit tumor growth in hepatocellular carcinoma

Oncotarget, 2017-05, Vol.8 (18), p.29771-29784

2017

Volltextzugriff (PDF)

Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathways

Journal of hematology and oncology, 2018-05, Vol.11 (1), p.73-73, Article 73

2018

Volltextzugriff (PDF)

Correction to: Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathways

Journal of hematology and oncology, 2018-07, Vol.11 (1), p.94-94, Article 94

2018

Volltextzugriff (PDF)

Corrigendum to “Pin1 inhibition reverses the acquired resistance of human hepatocellular carcinoma cells to Regorafenib via the Gli1/Snail/E-cadherin pathway” [Cancer Lett. 444 (2019) 82–93]

Cancer letters, 2024-11, Vol.604, p.217257, Article 217257

2024

Volltextzugriff (PDF)

Induction of IL-6Rα by ATF3 enhances IL-6 mediated sorafenib and regorafenib resistance in hepatocellular carcinoma

Cancer letters, 2022-01, Vol.524, p.161-171

2022

Volltextzugriff (PDF)

Association between DNA variant sites in the apolipoprotein A5 gene and coronary heart disease in Chinese

Metabolism, clinical and experimental, 2005-05, Vol.54 (5), p.568-572

2005

Volltextzugriff (PDF)

Integrative bioinformatics and experimental validation of hub genetic markers in acne vulgaris: Toward personalized diagnostic and therapeutic strategies

Journal of cosmetic dermatology, 2024-05, Vol.23 (5), p.1777-1799

2024

Volltextzugriff (PDF)

The Pin1-CaMKII-AMPA Receptor Axis Regulates Epileptic Susceptibility

Cerebral cortex (New York, N.Y. 1991), 2021-05, Vol.31 (6), p.3082-3095

2021

Volltextzugriff (PDF)

Pin1 inhibition potently suppresses gastric cancer growth and blocks PI3K/AKT and Wnt/β‐catenin oncogenic pathways

Molecular carcinogenesis, 2019-08, Vol.58 (8), p.1450-1464

2019

Volltextzugriff (PDF)

Inhibition of Death-associated Protein Kinase 1 protects against Epileptic Seizures in mice

International journal of biological sciences, 2021-01, Vol.17 (9), p.2356-2366

2021

Volltextzugriff (PDF)

Corrigendum to "Pin1 inhibition reverses the acquired resistance of human hepatocellular carcinoma cells to Regorafenib via the Gli1/Snail/E-cadherin pathway" Cancer Lett. 444 (2019) 82-93

Cancer letters, 2024-11, Vol.604, p.217257

2024

Volltextzugriff (PDF)

Targeting PIN 1 exerts potent antitumor activity in pancreatic ductal carcinoma via inhibiting tumor metastasis

Cancer science, 2019-08, Vol.110 (8), p.2442-2455

2019

Volltextzugriff (PDF)

1 – 25 von 115

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(95)
Mit Volltextzugriff
(101)

Publikationsform

Sprache

Englisch
(97)
Chinesisch
(18)

Erscheinungsjahr

n.n

Thema

Science & Technology
(73)
Life Sciences & Biomedicine
(34)
Humans
(29)
Physical Sciences
(23)
Technology
(21)
Male
(18)
Animals
(16)
Oncology
(14)
Female
(13)
Engineering
(12)
Mice
(11)
Diesel Engine
(10)
Energy & Fuels
(10)
Middle Aged
(10)
Biochemistry & Molecular Biology
(9)
Chemistry
(9)
Nima-Interacting Peptidylprolyl Isomerase - Genetics
(9)
Pin1
(9)
Diesel Engines
(8)
Phosphorylation
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The Astrophysical Journal
(5)
Astrophysical Journal/the astrophysical Journal
(4)
Cancer Letters
(4)
Rsc Advances
(3)
Scientific Reports
(3)
中国肺癌杂志
(3)
Annals Of Human Genetics
(2)
Cancer Science
(2)
Energy
(2)
Energy Reports
(2)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Pin1 Exacerbates Non-Alcoholic Fatty Liver Disease by Enhancing Its Activity through Binding to ACC1

Potential of the Antibody Against cis-Phosphorylated Tau in the Early Diagnosis, Treatment, and Prevention of Alzheimer Disease and Brain Injury

Pin1 inhibition reverses the acquired resistance of human hepatocellular carcinoma cells to Regorafenib via the Gli1/Snail/E-cadherin pathway

Pin1 Downregulation Is Involved in Excess Retinoic Acid-Induced Failure of Neural Tube Closure

Disorders of the central nervous system: Insights from Notch and Nrf2 signaling

Lead Induces Genotoxicity via Oxidative Stress and Promoter Methylation of DNA Repair Genes in Human Lymphoblastoid TK6 Cells

A novel controlled release formulation of the Pin1 inhibitor ATRA to improve liver cancer therapy by simultaneously blocking multiple cancer pathways

Targeting PIN1 exerts potent antitumor activity in pancreatic ductal carcinoma via inhibiting tumor metastasis

TCP1 regulates Wnt7b/β-catenin pathway through P53 to influence the proliferation and migration of hepatocellular carcinoma cells

MicroRNA-140-5p inhibits hepatocellular carcinoma by directly targeting the unique isomerase Pin1 to block multiple cancer-driving pathways

Regorafenib inhibits migration, invasion, and vasculogenic mimicry of hepatocellular carcinoma via targeting ID1‐mediated EMT

The role of peptidyl-prolyl isomerase Pin1 in neuronal signaling in epilepsy

Chemical or genetic Pin1 inhibition exerts potent anticancer activity against hepatocellular carcinoma by blocking multiple cancer-driving pathways

Inhibition of the prolyl isomerase Pin1 enhances the ability of sorafenib to induce cell death and inhibit tumor growth in hepatocellular carcinoma

Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathways

Correction to: Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathways

Corrigendum to “Pin1 inhibition reverses the acquired resistance of human hepatocellular carcinoma cells to Regorafenib via the Gli1/Snail/E-cadherin pathway” [Cancer Lett. 444 (2019) 82–93]

Induction of IL-6Rα by ATF3 enhances IL-6 mediated sorafenib and regorafenib resistance in hepatocellular carcinoma

Association between DNA variant sites in the apolipoprotein A5 gene and coronary heart disease in Chinese

Integrative bioinformatics and experimental validation of hub genetic markers in acne vulgaris: Toward personalized diagnostic and therapeutic strategies

The Pin1-CaMKII-AMPA Receptor Axis Regulates Epileptic Susceptibility

Pin1 inhibition potently suppresses gastric cancer growth and blocks PI3K/AKT and Wnt/β‐catenin oncogenic pathways

Inhibition of Death-associated Protein Kinase 1 protects against Epileptic Seizures in mice

Corrigendum to "Pin1 inhibition reverses the acquired resistance of human hepatocellular carcinoma cells to Regorafenib via the Gli1/Snail/E-cadherin pathway" Cancer Lett. 444 (2019) 82-93

Targeting PIN 1 exerts potent antitumor activity in pancreatic ductal carcinoma via inhibiting tumor metastasis

Suchergebnisse filtern